|
Zimmer Biomet Holdings Inc (ZBH) |
|
|
|
Zimmer Biomet Holdings Inc 's Total Debt to Equity
ZBH's quarterly Total Debt to Equity and Total Debt, Equity growth
Due to debt repayement of -3.98% Zimmer Biomet Holdings Inc improved Total Debt to Equity in third quarter 2023 to 0.44, below the company's average Total Debt to Equity.
Within Medical Equipment & Supplies industry in the third quarter 2023, 65 other companies have achieved lower Total Debt to Equity than Zimmer Biomet Holdings Inc in the III Quarter 2023. While Total Debt to Equity total ranking has improved so far in the third quarter 2023 to 1242, from total ranking in the second quarter 2023 at 1337 .
Explain Debt to Equity Ratio?
What is the structure of ZBH´s Total Debt?
How valuable is the ZBH´s Equity?
Select the Comparisons :
|
|
Select the Ratio:
|
|
ZBH Total Debt to Equity |
(Sep 30 2023) III. Quarter |
(Jun 30 2023) II. Quarter |
(Mar 31 2023) I. Quarter |
(Dec 31 2022) IV. Quarter |
(Sep 30 2022) III. Quarter |
Y / Y Equity Change |
2.18 % |
2.09 % |
1.13 % |
-5.05 % |
-3.64 % |
Y / Y Total Debt Change |
-4.06 % |
-5.22 % |
-8.11 % |
-19.41 % |
-23.85 % |
Total Debt to Equity MRQ |
0.44 |
0.46 |
0.48 |
0.47 |
0.47 |
ZBH's Total
Ranking |
# 1242 |
# 1337 |
# 455 |
# 1631 |
# 1251 |
Seq. Equity Change |
1.13 % |
1.82 % |
1.09 % |
-1.83 % |
1.04 % |
Seq. Total Debt Change |
-3.98 % |
-1.39 % |
1.64 % |
-0.31 % |
-5.14 % |
Total Debt to Equity third quarter 2023 Company Ranking |
Within: |
No. |
Medical Equipment & Supplies Industry |
# 66 |
Healthcare Sector |
# 196 |
Overall Market |
# 1242 |
Total Debt to Equity Statistics |
High |
Average |
Low |
1.19 |
0.75 |
0.27 |
(Sep 30 2015) |
|
(Dec 31 2013) |
Cumulative Zimmer Biomet Holdings Inc 's Total Debt to Equity
ZBH's Total Debt to Equity for the trailling 12 Months
ZBH Total Debt to Equity |
(Sep 30 2023) III. Quarter |
(Jun 30 2023) II. Quarter |
(Mar 31 2023) I. Quarter |
(Dec 31 2022) IV. Quarter |
(Sep 30 2022) III. Quarter |
Y / Y Equity TTM Growth |
2.18 % |
2.09 % |
1.13 % |
-5.05 % |
-3.64 % |
Y / Y Total Debt TTM Growth |
-4.06 % |
-5.22 % |
-8.11 % |
-19.41 % |
-23.85 % |
Total Debt to Equity TTM |
0.46 |
0.47 |
0.48 |
0.49 |
0.51 |
Total
Ranking TTM |
# 1449
| # 96
| # 12
| # 774
| # 970
|
Seq. Equity TTM Growth |
1.13 % |
1.82 % |
1.09 % |
-1.83 % |
1.04 % |
Seq. Total Debt TTM Growth |
-3.98 % |
-1.39 % |
1.64 % |
-0.31 % |
-5.14 % |
On the trailing twelve months basis Due to debt repayement of -3.98% Zimmer Biomet Holdings Inc decreased Total Debt to Equity in the 12 months ending in III Quarter 2023 to 0.46, below the company's average Total Debt to Equity. Total Debt to Equity is the average cumulative value over the last four quarters.
Among companies in the Medical Equipment & Supplies industry 76, during the past 12 months, other companies have achieved lower Total Debt to Equity than Zimmer Biomet Holdings Inc . While Total Debt to Equity total ranking has deteriorated during the twelve months ending in the III Quarter 2023, compared to the prior period, from 96 to 1449.
Explain Debt to Equity Ratio?
What is the structure of ZBH´s Total Debt?
How valuable is the ZBH´s Equity?
TTM Total Debt to Equity Company Ranking |
Within: |
No. |
Within the Medical Equipment & Supplies Industry |
# 77 |
Healthcare Sector |
# 269 |
Within the Market |
# 1449 |
trailing twelve months Total Debt to Equity Statistics |
High |
Average |
Low |
1.01 |
0.64 |
0.09 | (Dec 31 2017) |
|
(Jun 30 2017) |
Companies with similar Total Debt to Equity in the quarter ending Sep 30 2023, within Medical Equipment & Supplies Industry | Total Debt to Equity | Sep 30 2023 MRQ Total Debt | Sep 30 2023 MRQ Equity | Artivion Inc | 1.13 | $ 307.429 Millions | $ 271.975 Millions | Dexcom Inc | 1.13 | $ 2,556.600 Millions | $ 2,267.900 Millions | Acutus Medical Inc | 1.10 | $ 34.761 Millions | $ 31.706 Millions | Sonendo Inc | 0.98 | $ 37.202 Millions | $ 37.780 Millions | Zynex inc | 0.98 | $ 57.375 Millions | $ 58.582 Millions | Neuronetics Inc | 0.97 | $ 36.851 Millions | $ 37.941 Millions | Strata Skin Sciences Inc | 0.93 | $ 15.016 Millions | $ 16.193 Millions | Integra Lifesciences Holdings Corp | 0.91 | $ 1,429.303 Millions | $ 1,579.221 Millions | Medinotec Inc | 0.87 | $ 2.239 Millions | $ 2.567 Millions | Msa Safety Inc | 0.85 | $ 742.012 Millions | $ 868.726 Millions | Haemonetics Corporation | 0.85 | $ 762.228 Millions | $ 893.660 Millions | | 0.84 | $ 4.000 Millions | $ 4.786 Millions | Carlisle Companies Incorporated | 0.78 | $ 2,285.500 Millions | $ 2,923.800 Millions | Icu Medical Inc | 0.78 | $ 1,634.932 Millions | $ 2,098.356 Millions | Cadre Holdings inc | 0.76 | $ 143.560 Millions | $ 189.997 Millions | Zimvie Inc | 0.73 | $ 515.533 Millions | $ 710.199 Millions | Masimo Corp | 0.71 | $ 910.100 Millions | $ 1,275.600 Millions | National Vision Holdings Inc | 0.67 | $ 562.827 Millions | $ 840.352 Millions | Nevro Corp | 0.66 | $ 187.803 Millions | $ 285.666 Millions | Bausch and Lomb Corp | 0.65 | $ 4,465.000 Millions | $ 6,883.000 Millions | Integer Holdings Corporation | 0.64 | $ 941.383 Millions | $ 1,463.349 Millions | Outset Medical Inc | 0.64 | $ 96.784 Millions | $ 152.063 Millions | Infusystem Holdings Inc | 0.63 | $ 32.655 Millions | $ 51.469 Millions | Becton Dickinson And Company | 0.62 | $ 15,879.000 Millions | $ 25,796.000 Millions | Glaukos Corp | 0.59 | $ 282.430 Millions | $ 477.659 Millions | Dentsply Sirona Inc | 0.59 | $ 1,990.000 Millions | $ 3,371.000 Millions | P3 Health Partners Inc | 0.58 | $ 108.252 Millions | $ 187.943 Millions | Steris Plc | 0.56 | $ 3,437.179 Millions | $ 6,189.168 Millions | Intelligent Bio Solutions Inc | 0.52 | $ 0.648 Millions | $ 1.237 Millions | Beyond Air Inc | 0.50 | $ 14.319 Millions | $ 28.831 Millions |
|